A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of RO 6807952 in Type 2 Diabetic Patients Inadequately Controlled with Metformin Alone.
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs RG 7685 (Primary) ; Liraglutide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 13 Feb 2012 Actual patient number (2) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Planned End Date changed from 1 Dec 2012 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 13 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.